We first observed an enrichment of early NK cells (CD56+CD57−) (p < 0.001) (Figure S4A) in benign ovarian tumors compared to ovarian cancer, while late NK cell levels did not differ significantly (Figure S4B). This evidence concerns the gene B3GAT1 and ovarian benign neoplasm.